Revvity RVTY
NYSE RVTY
$146.80 +1.07 (+0.73%)
As of: Sep 17, 2026 · 3:59 PM EDT

Revvity (RVTY) Total Non-Current Liabilities (2010 - 2026)

Revvity's (RVTY) quarterly Total Non-Current Liabilities came in at $4.0 billion in Q3 2026, down 15.46% on a YoY basis from $4.8 billion in Q3 2025, and down 15.52% quarter-over-quarter from $4.8 billion in Q2 2026.

Analysis

Revvity (RVTY) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

Revvity (RVTY) has reported Total Non-Current Liabilities for 17 consecutive years, with $4.0 billion the latest figure, recorded in Q3 2026.

  • For the quarter ending Q3 2026, Total Non-Current Liabilities fell 15.46% year-over-year to $4.0 billion; the trailing twelve-month figure through Jul 2026 stood at $4.0 billion (down 15.46% YoY), and the FY2025 full-year result was $4.1 billion, down 12.61% from the prior year.
  • Total Non-Current Liabilities fell to $4.0 billion in Q3 2026 per RVTY's latest filing, from $4.8 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $7.8 billion in Q1 2022 and bottomed at $4.0 billion in Q3 2024.
  • Historically, Total Non-Current Liabilities has averaged $5.5 billion across 5 years, with a median of $5.5 billion in 2024.
  • The sharpest annual moves came in 2022 and 2024: Total Non-Current Liabilities jumped 84.78% in 2022, then retreated 16.77% in 2024.
  • Over 5 years, Total Non-Current Liabilities stood at $5.5 billion in 2022, then rose by 2.26% to $5.7 billion in 2023, then retreated by 16.77% to $4.7 billion in 2024, then declined by 12.61% to $4.1 billion in 2025, then retreated by 1.58% to $4.0 billion in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $4.0 billion, $4.8 billion, and $4.1 billion for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 55.95 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn 33.25 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 6.06 Bn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn 3.52 Bn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn 4.05 Bn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn 457.16 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn 2.88 Bn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn 821.06 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn 197.96 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn 3.06 Bn
Historic Data

Historic Data

Download Data
DateValue
Jul 5, 2026 4.05 Bn
Apr 5, 2026 4.79 Bn
Dec 28, 2025 4.11 Bn
Sep 28, 2025 4.01 Bn
Jun 29, 2025 4.79 Bn
Mar 30, 2025 4.70 Bn
Dec 29, 2024 4.70 Bn
Sep 29, 2024 4.00 Bn
Jun 30, 2024 5.52 Bn
Mar 31, 2024 5.56 Bn
Dec 31, 2023 5.65 Bn
Oct 1, 2023 4.73 Bn
Jul 2, 2023 6.31 Bn
Apr 2, 2023 6.56 Bn
Jan 1, 2023 6.70 Bn
Oct 2, 2022 5.53 Bn
Jul 3, 2022 6.97 Bn
Apr 3, 2022 7.61 Bn
Jan 2, 2022 7.80 Bn
Oct 3, 2021 6.43 Bn